Showing results (131-140 of 745) with videos related to

Sort By:
Pageof 75
Circulation. Cardiovascular Quality and Outcomes|January 13, 2018
Prior Authorization Requirements for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Across US Private and Public PayersJalpa A Doshi, Justin T Puckett, Michael S Parmacek, et al.
Hepatology Communications|September 14, 2020
Self-Organizing Human Induced Pluripotent Stem Cell Hepatocyte 3D Organoids Inform the Biology of the Pleiotropic <i>TRIB1</i> GeneDeepti Abbey, Susannah Elwyn, Nicholas J Hand, et al.
The American Journal of Cardiology|March 21, 2003
Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatinDaniel J Rader, Michael H Davidson, Richard J Caplan, et al.
Plos One|July 14, 2011
VLDL hydrolysis by hepatic lipase regulates PPARδ transcriptional responsesJonathan D Brown, Eric Oligino, Daniel J Rader, et al.
Biostatistics (Oxford, England)|September 22, 2011
A Gaussian copula approach for the analysis of secondary phenotypes in case-control genetic association studiesJing He, Hongzhe Li, Andrew C Edmondson, et al.
European Journal of Heart Failure|May 28, 2013
Anti-oxidative and cholesterol efflux capacities of high-density lipoprotein are reduced in ischaemic cardiomyopathyParin J Patel, Amit V Khera, Robert L Wilensky, et al.
Current Opinion in Lipidology|September 19, 2017
New insights into the role of glycosylation in lipoprotein metabolismMarjolein A W van den Boogert, Daniel J Rader, Adriaan G Holleboom
Trends in Molecular Medicine|March 19, 2016
Therapeutic Targets of Triglyceride Metabolism as Informed by Human GeneticsRobert C Bauer, Sumeet A Khetarpal, Nicholas J Hand, et al.
Gastroenterology|December 8, 2010
Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in miceNiels Nijstad, Thomas Gautier, François Briand, et al.
Biomedicines|December 24, 2021
Dynamic Changes in Central and Peripheral Neuro-Injury vs. Neuroprotective Serum Markers in COVID-19 Are Modulated by Different Types of Anti-Viral Treatments but Do Not Affect the Incidence of Late and Early StrokesKrzysztof Laudanski, Jihane Hajj, Mariana Restrepo, et al.
Pageof 75